Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
The use of egg yolk antibodies—IgY technology—represents an alternative to the production of mammalian immunoglobulins and has several advantages regarding animal welfare and lower costs of production. The use of adjuvants to achieve the hyperimmunization of laying hens plays a key role in the succe...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | info:ar-repo/semantics/artículo |
| Language: | Inglés |
| Published: |
Springer
2023
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.12123/13956 https://link.springer.com/article/10.1007/s00253-023-12409-3 https://doi.org/10.1007/s00253-023-12409-3 |
Similar Items: Use of adjuvant ISA VG 71 to produce neutralizing egg yolk antibodies against bothropic venom
- In vivo neutralization of bee venom lethality by IgY antibodies
- IgY technology: producing antibodies from a 3Rs perspective
- IgY-based antivenom against Bothrops alternatus: Production and neutralization efficacy
- IgY-technology (egg yolk antibodies) in human medicine: a review of patents and clinical trials
- Development and validation of a novel ELISA for the detection of Neospora caninum antibodies in bovine sera
- A simple and economic three-step process for producing highly purified Fab’ fragments directly from the egg yolk water-soluble fraction